Michael L. Chang's most recent trade in Nutex Health Inc was a trade of 2,500 Restricted Stock Units done . Disclosure was reported to the exchange on March 1, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Nutex Health Inc | Michael L. Chang | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 2,500 | 5,000 | - | - | Restricted Stock Units | |
Nutex Health Inc | Michael L. Chang | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 1,250 | 81,307 | - | 0 | Common Stock | |
Nutex Health Inc | Michael L. Chang | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.10 per share. | 01 Mar 2025 | 266 | 81,041 | - | 72.1 | 19,178 | Common Stock |
Nutex Health Inc | Michael L. Chang | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 37,500 | 37,500 | - | - | Restricted Stock Unit | |
Nutex Health Inc | Michael L. Chang | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 12,008,523 | 12,008,523 | - | - | Common Stock |